Relative contribution of target gene mutation and efflux to varying quinolone resistance in Irish Campylobacter isolates

被引:21
作者
Corcoran, D
Quinn, T
Cotter, L
Fanning, S [1 ]
机构
[1] Univ Coll Dublin, Ctr Food Safety, Sch Agr Food Sci & Vet Med, Dublin 4, Ireland
[2] Cork Inst Technol, Mol Diagnost Unit, Cork, Ireland
关键词
Campylobacter; gyrA mutation; efflux pumps; efflux pump inhibitor Phe-Arg-beta-Naphthylamide;
D O I
10.1016/j.femsle.2005.09.019
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The contribution of target gene mutations and active efflux to varying levels of quinolone resistance in Irish Campylobacter isolates was studied. The Thr-86-Ile modification of GyrA did not correlate with the level of quinolone resistance. The efflux pump inhibitor Phe-Arg-beta-Naphthylamide (PA beta N) had no effect on the MICs to ciprofloxacin. In contrast, a PA beta N sensitive efflux system contributed to the low-level nalixidic acid resistance phenotype. The lack of effect of PA beta N in high-level resistant nalidixic isolates may be attributable to mutations identified in the CmeB efflux pump of these isolates. PA beta N may have limited diagnostic value in the assessment of the contribution of efflux pump activity to ciprofloxacin resistance in Campylobacter. (c) 2005 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:39 / 46
页数:8
相关论文
共 39 条
[1]  
AHMED M, 1993, J BIOL CHEM, V268, P11086
[2]   PCR-restriction fragment length polymorphism assay for detection of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli [J].
Alonso, R ;
Mateo, E ;
Girbau, C ;
Churruca, E ;
Martinez, I ;
Fernández-Astorga, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) :4886-4888
[3]   Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae [J].
Baranova, NN ;
Neyfakh, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1396-1398
[4]   The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar typhimurium phage type DT204 [J].
Baucheron, S ;
Imberechts, H ;
Chaslus-Dancla, E ;
Cloeckaert, A .
MICROBIAL DRUG RESISTANCE, 2002, 8 (04) :281-289
[5]   Efflux and target mutations as quinolone resistance mechanisms in clinical isolates of Streptococcus pneumoniae [J].
Broskey, J ;
Coleman, K ;
Gwynn, MN ;
McCloskey, L ;
Traini, C ;
Voelker, L ;
Warren, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 :95-99
[6]   A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates [J].
Coban, AY ;
Ekinci, B ;
Durupinar, B .
CHEMOTHERAPY, 2004, 50 (01) :22-26
[7]   An investigation of the molecular mechanisms contributing to high-level erythromycin resistance in Campylobacter [J].
Corcoran, D ;
Quinn, T ;
Cotter, L ;
Fanning, S .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 27 (01) :40-45
[8]   Identification of ciprofloxacin-resistant Campylobacter jejuni and analysis of the gyrA gene by the LightCycler mutation assay [J].
Dionisi, AM ;
Luzzi, I ;
Carattoli, A .
MOLECULAR AND CELLULAR PROBES, 2004, 18 (04) :255-261
[9]   Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli [J].
Ge, BL ;
McDermott, PF ;
White, DG ;
Meng, JH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) :3347-3354
[10]   INHIBITION OF DNASE ACTIVITY IN PFGE ANALYSIS OF DNA FROM CAMPYLOBACTER-JEJUNI [J].
GIBSON, JR ;
SUTHERLAND, K ;
OWEN, RJ .
LETTERS IN APPLIED MICROBIOLOGY, 1994, 19 (05) :357-358